There are studies that suggest that IgA anti-β2GPI is associated with thrombosis in patients with lupus (OR 2.8, 95% CI 1.3 to 6.2) [33], as well as a higher risk of acute myocardial infarction and stroke [34]. This evidence concerns the gene CD79A and systemic lupus erythematosus.